Annual Report

Overview

The report shows a year of revenue growth and renewed vaccine expansion. Consolidated revenue from operations increased by approximately 15% to ₹ 6,248 million in FY2021, while Panacea Biotec and PBPL together reported around 2,895 employees. The company also agreed with RDIF to produce up to 100 million Sputnik V doses annually in India. Its vaccine pipeline advanced through completed Phase I/II dengue and Phase I pneumococcal vaccine studies.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020-2021
Period: 1 April 2020 – 31 March 2021
Publication date: 23 July 2021
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services